GGTLC1 and inflammatory bowel disease: Enzymatic cholestasis in patients with IBD can be assessed by measuring the serum level of bile salts, bilirubin, alkaline phosphatase (ALP), and/or gamma-glutamyl transpeptidase (GGT).